ALKS · Alkermes plc.

$49.06 -0.39 (-0.79%) At close · Aug 14

Market Cap

$8.27B

167.76M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard F. Pops	Chief Executive Officer and Chairman	$1,250,769	—	—	$5,020,812	$1,626,000	$17,500	$7,915,081
Blair C. Jackson	Executive Vice President, Chief Operating Officer; Former Interim Principal Financial Officer	$736,450	—	$1,333,356	$1,324,981	$618,618	$17,500	$4,030,905
Blair Jackson	COO	$736,450	—	$1,333,356	$1,324,981	$618,618	$17,500	$4,030,905
Joshua Reed	Senior Vice President, Chief Financial Officer	$181,978	—	$1,155,031	$2,334,091	$118,286	$7,688	$3,797,074
Craig Hopkinson	Executive Vice President, Research and Development and Chief Medical Officer	$764,837	—	$1,100,001	$1,093,107	$642,463	$17,500	$3,617,908
David J. Gaffin	Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary	$684,497	—	$1,100,001	$1,093,107	$574,978	$17,500	$3,470,083
Todd Nichols	Senior Vice President, Chief Commercial Officer	$614,869	—	$866,683	$861,234	$430,408	$17,500	$2,790,694

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard F. Pops	Chief Executive Officer and Chairman	$1,214,339	—	$3,640,820	$4,044,445	$1,214,339	$17,250	$10,131,193
Blair Jackson	COO	$715,000	—	$1,699,940	$1,986,944	$471,900	$17,250	$4,891,034
Blair C. Jackson	Executive Vice President, Chief Operating Officer and Chief Risk Officer; Interim Principal Financial Officer	$715,000	—	$1,699,940	$1,986,944	$471,900	$17,250	$4,891,034
Craig Hopkinson	Executive Vice President, Research and Development and Chief Medical Officer	$742,560	—	$1,454,864	$1,639,227	$490,090	$17,250	$4,343,991
David J. Gaffin	Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary	$664,560	—	$1,395,582	$1,639,227	$398,736	$17,250	$4,115,355
Todd Nichols	Senior Vice President, Chief Commercial Officer	$596,960	—	$1,114,855	$1,291,526	$298,480	$17,250	$3,319,071
Iain M. Brown	Senior Vice President, Chief Financial Officer	$256,715	—	$1,154,409	$1,341,196	$50,000	$17,250	$2,819,570

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard F. Pops	Chief Executive Officer and Chairman	$1,178,970	—	$2,897,991	$3,933,841	$1,414,764	$16,500	$9,442,066
Blair C. Jackson	Executive Vice President, Chief Operating Officer and Chief Risk Officer; Interim Principal Financial Officer	$650,000	—	$1,495,711	$1,892,704	$507,000	$16,500	$4,561,915
Blair Jackson	COO	$650,000	—	$1,495,711	$1,892,704	$507,000	$16,500	$4,561,915
Craig Hopkinson	Executive Vice President, Research and Development and Chief Medical Officer	$714,000	—	$1,316,222	$1,665,586	$514,080	$16,500	$4,226,388
David J. Gaffin	Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary	$639,000	—	$1,316,222	$1,665,586	$498,420	$16,500	$4,135,728
Iain M. Brown	Senior Vice President, Chief Financial Officer	$575,000	—	$997,141	$1,261,808	$359,375	$16,500	$3,209,824

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard F. Pops	Chief Executive Officer and Chairman	$1,144,631	—	$4,157,121	$3,852,539	$1,144,631	$15,250	$10,314,172
Craig Hopkinson	Executive Vice President, Research and Development and Chief Medical Officer	$693,000	—	$1,625,016	$1,797,854	$415,800	$15,250	$4,546,920
Blair C. Jackson	Executive Vice President, Chief Operating Officer and Chief Risk Officer; Interim Principal Financial Officer	$600,000	—	$1,625,016	$1,797,854	$432,000	$15,250	$4,470,120
Blair Jackson	COO	$600,000	—	$1,625,016	$1,797,854	$432,000	$15,250	$4,470,120
David J. Gaffin	Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary	$614,201	—	$1,533,595	$1,682,506	$446,400	$15,250	$4,291,952
Iain M. Brown	Senior Vice President, Chief Financial Officer	$550,000	—	$1,160,755	$1,284,189	$302,500	$15,250	$3,312,694

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard F. Pops	Chairman and Chief Executive Officer	$1,105,923	—	$3,101,695	$3,463,250	$1,161,220	$14,500	$8,846,588
Craig Hopkinson	Executive Vice President, Research and Development and Chief Medical Officer	$670,000	—	$1,612,178	$1,988,600	$442,200	$14,500	$4,727,478
Blair C. Jackson	Executive Vice President, Chief Operating Officer and Chief Risk Officer	$540,000	—	$1,272,775	$1,569,949	$372,600	$14,500	$3,769,824
Blair Jackson	COO	$540,000	—	$1,272,775	$1,569,949	$372,600	$14,500	$3,769,824
David J. Gaffin	Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary	$586,250	—	$975,790	$1,203,632	$337,094	$14,500	$3,117,266
Iain M. Brown	Senior Vice President, Chief Financial Officer	$500,000	—	$933,373	$1,151,296	$287,500	$14,500	$2,886,669

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard F. Pops	Chairman and Chief Executive Officer	$1,073,712	—	$2,551,714	$3,489,121	$912,655	$14,500	$8,041,702
Craig Hopkinson	Executive Vice President, Research and Development and Chief Medical Officer	$650,000	—	$1,298,079	$1,643,556	$351,000	$14,500	$3,957,135
David J. Gaffin	Senior Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary	$569,250	—	$904,709	$1,145,513	$256,163	$14,500	$2,890,136
Mr. James M. Frates	Former Senior Vice President, Chief Financial Officer	$575,460	—	$786,717	$996,096	—	$14,500	$2,372,772
Michael J. Landine	Senior Vice President, Corporate Development and Chief Risk Officer	$516,465	—	$688,373	$871,585	$219,498	$14,500	$2,310,421

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard F. Pops	Chairman and Chief Executive Officer	$1,037,400	—	$4,221,072	$8,384,675	$980,000	$14,000	$14,637,147
James A. Robinson	Former President and Chief Operating Officer	$268,991	—	$1,315,828	$2,556,639	—	$13,615	$4,155,073
Craig Hopkinson	Executive Vice President, Research and Development and Chief Medical Officer	$621,000	—	$895,675	$1,737,537	$388,125	$14,000	$3,656,337
David J. Gaffin	Senior Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary	$550,000	—	$895,675	$1,737,537	$343,750	$14,000	$3,540,962
Mr. James M. Frates	Former Senior Vice President, Chief Financial Officer	$556,000	—	$758,881	$1,475,360	$278,000	$14,000	$3,082,241
Michael J. Landine	Senior Vice President, Corporate Development and Chief Risk Officer	$499,000	—	$758,881	$1,475,360	$249,500	$14,000	$2,996,741

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard F. Pops	Chairman and Chief Executive Officer	$1,002,316	—	$4,876,350	$10,010,722	$1,152,664	$13,750	$17,055,802
James A. Robinson	Former President and Chief Operating Officer	$545,192	—	$1,104,000	$3,159,506	$633,000	$1,286,170	$6,727,868
Craig Hopkinson	Executive Vice President, Research and Development and Chief Medical Officer	$600,000	—	$908,010	$1,849,438	$420,000	$13,750	$3,791,198
Mr. James M. Frates	Former Senior Vice President, Chief Financial Officer	$536,732	—	$908,010	$1,849,438	$309,000	$13,750	$3,616,930
David J. Gaffin	Senior Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary	$500,000	—	$908,010	$1,849,438	$325,000	$13,750	$3,596,198

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard F. Pops	Chairman and Chief Executive Officer	$964,204	—	$1,909,950	$5,379,155	$1,113,684	$13,500	$9,380,493
Mr. James M. Frates	Senior Vice President, Chief Financial Officer	$517,232	—	$654,840	$1,344,789	$298,184	$13,500	$2,828,545

Executive changes

Person	Role	Change	Effective	Filed
Christopher I. Wright, M.D., Ph.D.	director	Appointed	2026-05-20	2026-05-20
Frank Anders Wilson	director	Appointed	2026-05-20	2026-05-20
Nancy L. Snyderman, M.D.	director	Appointed	2026-05-20	2026-05-20
Richard F. Pops	director	Appointed	2026-05-20	2026-05-20
Brian P. McKeon	director	Appointed	2026-05-20	2026-05-20
Nancy S. Lurker	director	Appointed	2026-05-20	2026-05-20
Cato T. Laurencin, M.D., Ph.D.	director	Appointed	2026-05-20	2026-05-20
Richard B. Gaynor, M.D.	director	Appointed	2026-05-20	2026-05-20
Shane M. Cooke	director	Appointed	2026-05-20	2026-05-20
Blair C. Jackson	Chief Executive Officer	Appointed	2026-08-01	2026-02-25
Richard F. Pops	Chief Executive Officer	Retired	2026-07-31	2026-02-25
Joshua Reed	Senior Vice President, Chief Financial Officer	Appointed	2025-09-15	2025-09-12
Nancy S. Lurker	Board	Appointed	2024-03-05	2024-03-07
Samuel J. Parisi	interim principal accounting officer	Appointed	2024-02-01	2024-02-05
Blair C. Jackson	interim principal financial officer	Appointed	2024-02-01	2024-02-05
Frank Anders Wilson	Lead Independent Director of the Board	Appointed	2023-12-08	2023-12-08
Nancy J. Wysenski	board of directors	Retired	2023-12-08	2023-12-08
Christopher I. Wright, M.D., Ph.D.	director	Appointed	2023-06-29	2023-07-06
Cato T. Laurencin, M.D., Ph.D.	director	Appointed	2023-06-29	2023-07-06
Brian P. McKeon	director	Appointed	2023-06-29	2023-07-06
Richard F. Pops	director	Appointed	2023-06-29	2023-07-06
Shane M. Cooke	director	Appointed	2023-06-29	2023-07-06
Richard B. Gaynor, M.D.	director	Appointed	2023-06-29	2023-07-06
Emily Peterson Alva	director	Appointed	2023-06-29	2023-07-06
Christopher I. Wright, M.D., Ph.D.	Class II director	Appointed	2022-07-07	2022-07-07

Key facts CIK 1520262 CUSIP G01767105 13F (30d) 407 filings 389 filers Visit website Investor relations